1,3-dipropyl-8-cyclopentylxanthine has been researched along with fk 838 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akahane, A; Katayama, H; Kato, T; Kinoshita, T; Kita, Y; Kusunoki, T; Mitsunaga, T; Shiokawa, Y; Terai, T; Yoshida, K | 1 |
Akahane, A; Durkin, K; Itani, H; Kinoshita, T; Kuroda, S; Nishimura, S; Sakane, K; Tenda, Y | 1 |
Bondavalli, F; Botta, M; Bruno, O; Ciacci, A; Corelli, F; Fossa, P; Lucacchini, A; Manetti, F; Martini, C; Menozzi, G; Mosti, L; Ranise, A; Schenone, S; Tafi, A; Trincavellic, ML | 1 |
El-Tayeb, A; Inamdar, GS; Li, W; Müller, CE; Scheiff, AB; Sudarsanam, V; Vasu, KK; Yerande, SG | 1 |
Arima, S; Endo, Y; Ito, O; Ito, S; Omata, K; Takeuchi, K; Yaoita, H | 1 |
5 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and fk 838
Article | Year |
---|---|
Discovery of 6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)- pyridazinebutanoic acid (FK 838): a novel non-xanthine adenosine A1 receptor antagonist with potent diuretic activity.
Topics: Administration, Oral; Animals; Diuretics; Drug Design; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 1999 |
Discovery of FR166124, a novel water-soluble pyrazolo-[1,5-a]pyridine adenosine A1 receptor antagonist.
Topics: Antihypertensive Agents; Inhibitory Concentration 50; Molecular Structure; Piperidines; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Receptors, Purinergic P1; Solubility; Structure-Activity Relationship; Water; Xanthines | 1999 |
Synthesis, molecular modeling studies, and pharmacological activity of selective A(1) receptor antagonists.
Topics: Animals; Binding, Competitive; Cattle; Cerebral Cortex; Ligands; Models, Molecular; Purinergic P1 Receptor Antagonists; Pyridines; Radioligand Assay; Receptors, Purinergic P1; Structure-Activity Relationship | 2002 |
2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Topics: Adenosine A1 Receptor Antagonists; Animals; Drug Design; Humans; Molecular Structure; Rats; Receptor, Adenosine A1; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2010 |
[Effect of adenosine on isolated afferent arterioles].
Topics: Adenosine; Animals; Arterioles; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney; Male; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyridines; Rabbits; Theobromine; Vasoconstriction; Vasodilation; Vasodilator Agents; Xanthines | 1999 |